Indian Immunologicals to set up new vaccine plant in Puducherry

The proposed new investment in Puducherry is a part of the union government's strategy to meet the anticipated doubling of demand for veterinary vaccines.

id-100225935-1

IIL is investing Rs 300 crore in the new facility

Vaccine manufacturer Indian Immunologicals Ltd (IIL), part of the National Dairy Development Board (NDDB), is setting up a new vaccine manufacturing facility in Puducherry involving an investment of Rs 300 crore, says reports.

"The proposed new investment in Puducherry is a part of the union government's strategy to meet the anticipated doubling of demand for veterinary vaccines. It is estimated to reach 600 million doses over the next 3-4 years from around 300 million doses now," said NDDB chairman Mr T Nnda Kumar in a statement.

However, the decision on whether to manufacture new vaccines at the proposed facility or expand the existing portfolio is yet to be taken. Reportedly, the land for the vaccine production facility is already acquired.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X